Permethrin

Overview

A pyrethroid insecticide commonly used in the treatment of lice infestations and scabies. It is a yellow to light orange-brown, low melt-ing solid or viscous liquid.

Indication

For the treatment of infestation with Sarcoptes scabiei (scabies).

Associated Conditions

Head Lice Infestation
Norwegian scabies
Scabies
Lice of the pubic area

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies	2025/03/26	NCT06896929	Phase 2	Not yet recruiting	Children Hospital and Institute of Child Health, Lahore
Sulfur vs. Different Regimes of Permethrin for Scabies	2024/05/02	NCT06396507	Phase 3	Completed	Damascus University
Therapy for Scabies With Two Differently Concentrated Permethrin Creams	2024/04/23	NCT06380452	Phase 3	Not yet recruiting	Infectopharm Arzneimittel GmbH
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies	2023/05/17	NCT05862701	Phase 1	Completed	Combined Military Hospital Abbottabad
Ivermectin/ Permethrin for Scabies	2023/04/19	NCT05819983	Phase 4	Completed	Universitas Padjadjaran
Comparison of Oral Ivermectin and Permethrin 5% Lotion in Treatment of Pediculosis Capitis	2022/12/09	NCT05643820	Phase 1	Completed	Combined Military Hospital Abbottabad
Comparative Study Between Topical Permethrin 5% and Oral Ivermectin for the Treatment of Scabies	2022/05/05	NCT05362513	Phase 1	Completed	Combined Military Hospital Abbottabad
Better Disease Control by Multidrug Regimen in Scabies	2022/01/20	NCT05198947	Not Applicable	Completed	B.P. Koirala Institute of Health Sciences
Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)	2021/03/24	NCT04814511	Phase 3	UNKNOWN	Infectopharm Arzneimittel GmbH
Ivermectin Safety in Small Children	2020/04/02	NCT04332068	Phase 2	Recruiting	University of Oxford

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
Permethrin	Actavis Pharma, Inc.	0472-0242	TOPICAL	50 mg in 1 g	12/31/2019
Permethrin	Rebel Distributors Corp	21695-907	TOPICAL	50 mg in 1 g	1/5/2007
Permethrin	NuCare Pharmaceuticals,Inc.	68071-3316	TOPICAL	50 mg in 1 g	2/12/2021
Permethrin	NuCare Pharmaceuticals,Inc.	68071-1627	TOPICAL	50 mg in 1 g	1/28/2022
Permethrin	Physicians Total Care, Inc.	54868-5391	TOPICAL	50 mg in 1 g	6/1/2012
Permethrin	Northstar Rx LLC	16714-897	TOPICAL	50 mg in 1 g	4/8/2019
Permethrin	Preferred Pharmaceuticals Inc.	68788-8439	TOPICAL	50 mg in 1 g	6/5/2023
Permethrin	H.J. Harkins Company, Inc.	52959-159	TOPICAL	50 mg in 1 g	2/10/2012
Permethrin	Padagis Israel Pharmaceuticals Ltd	45802-269	TOPICAL	50 mg in 1 g	1/10/2017
Permethrin	Central Texas Community Health Centers	76413-159	TOPICAL	50 mg in 1 g	3/1/2018

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
LYCLEAR SCABIES CREAM	46343	Perrigo Australia Pty Ltd	Medicine	A	9/7/1993

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
NIX DERMAL CREAM	haleon canada ulc	02219905	Cream - Topical	5 % / W/W	7/1/1999
KWELLADA-P CRÈME RINSE	medtech products inc	02231480	Liquid - Topical	1 %	11/16/1998
NIX DERMAL CREAM 5%	burroughs wellcome inc., consumer prod division	01943154	Cream - Topical	5 %	12/31/1991
NIX CREME RINSE	insight pharmaceuticals, llc	00771368	Cream - Topical	1 %	12/31/1988
KWELLADA-P LOTION	medtech products inc	02231348	Lotion - Topical	5 %	10/16/1997

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
PERME-CURE 50 MG/G CREMA	Galenicum Derma S.L.U.	64052	CREMA	Medicamento Sujeto A Prescripción Médica	Commercialized
SARCOP 50 MG/G CREMA	Unipharma S.A.	62971	CREMA	Medicamento Sujeto A Prescripción Médica	Commercialized

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

Related News

Congressional Lawmakers Push for Fast-Track Approval of Antiparasitic Treatments as New World Screwworm Threat Approaches U.S. Border

3 months ago

Congressional lawmakers led by Rep. Tony Gonzales and Rep. Kat Cammack are urging federal agencies to expedite approval of antiparasitic treatments for livestock to combat the approaching New World screwworm threat.

Help Us Improve

Your feedback helps us provide better drug information and insights.

AI-Powered Research

Premium Access